Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections
A collaborative project financed by the EC Framework Programme 7
Objective: To assess the safety and immunogenicity of second generation viral vectored technology using ChAd3 and MVA, employing NSmut linked to the human MHC class II invariant chain, in both healthy subjects and HIV-positive patients (PEACHI-03).
Work Package Lead: Kantonsspital, St Gallen
Summary of Tasks: